Showing results (461-470 of 472) with videos related to

Sort By:
Pageof 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2016
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trialS Loibl, C Jackisch, A Schneeweiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trialC Denkert, S Loibl, B M Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)G von Minckwitz, M Rezai, H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapyJ L Lindner, S Loibl, C Denkert, et al.
Genome Announcements|August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and MontyWelkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
American Journal of Medical Genetics. Part A|February 29, 2024
De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delayThoa Ha, Angela Morgan, Meghan N Bartos, et al.
Pageof 48